EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinie

Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis

Jerrold H Levy, Joseph R Shaw, Deborah M Siegal, Jeannie Callum, Corinne Frere, Keyvan Karkouti, Cheryl L Maier, Michael Mazzeffi, C Marc Samama, Risa Shorr, Kenichi A Tanaka, Cornelius M Dyke und 1 weitere

Journal of Thrombosis and Haemostasis · 2026-11 · 24 (11) · 3853-3864

DOI: 10.1016/j.jtha.2026.07.030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-11. Verfasst von Jerrold H Levy und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina, USA; Centre for Blood Research…. Hauptthemen laut MEDLINE: Blood Coagulation Factors, Perioperative Care, Hemostasis, Blood Loss, Surgical. Die Arbeit nennt 83 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perioperative bleeding remains a major cause of morbidity and resource utilization in patients undergoing major surgery, including cardiac, trauma, obstetrical, and organ transplant surgery. Acquired perioperative coagulopathy is multifactorial and may result from blood loss, hemodilution, hypothermia, acidosis, fibrinolysis, inflammation, and consumption of coagulation factors and platelets. Over the past decade, coagulation factor concentrates have increasingly been incorporated into perioperative bleeding management algorithms because of their rapid availability, standardized dosing, lower infusion volumes, and pathogen inactivation, reducing dependence on plasma products. Since the 2018 publication of the International Society on Thrombosis and Haemostasis (ISTH) guidance on the use of factor concentrates for the management of perioperative bleeding, additional clinical studies, systematic reviews, and evolving bleeding management practices have expanded the evidence base for the use of fibrinogen concentrate, prothrombin complex concentrate, recombinant activated factor (F)VII, and FXIII concentrate for surgically acquired coagulopathy. This guidance document from the Perioperative and Critical Care Subcommittee of the ISTH reviews the current literature and provides pragmatic guidance on the perioperative use of coagulation factor concentrates based on available evidence and expert consensus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Coagulation FactorsPerioperative CareHemostasisBlood Loss, SurgicalCritical CareBlood CoagulationCoagulantsHemostaticsPostoperative HemorrhageHumansFactor VIIaTreatment Outcome

Stichwörter der Autor:innen

Blood Loss, Surgicalfactor VIIafactor XIIIfibrinogenprothrombin complex concentrates

Substanzen

Blood Coagulation Factorsprothrombin complex concentratesCoagulantsHemostaticsFactor VIIa

Autor:innen und Institutionen

  • Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina, USA; Centre for Blood Research, Pathology and Laboratory Medicine, University of British Columbia, V…
  • Inflammation and Chronic Disease Program, The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Inflammation and Chronic Disease Program, The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Queen's University, Kingston, Ontario, Canada.
  • Unité de recherche sur les maladies cardiovasculaires et métaboliques (UMR-S 1166), Sorbonne Université; Assistance Publique-Hôpitaux de Paris. Pitié-Salpêtrière Hospital, Paris, France.
  • Department of Anesthesia and Pain Management, University Health Network, Sinai Health System, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.

Zitieren

APA

Levy, J. H., Shaw, J. R., Siegal, D. M., Callum, J., Frere, C., Karkouti, K., Maier, C. L., Mazzeffi, M., Samama, C. M., Shorr, R., Tanaka, K. A., Dyke, C. M., & Connors, J. M. (2026). Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis, 24(11), 3853-3864. https://doi.org/10.1016/j.jtha.2026.07.030

Vancouver

Levy JH, Shaw JR, Siegal DM, Callum J, Frere C, Karkouti K, et al. Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 2026;24(11):3853-3864. doi:10.1016/j.jtha.2026.07.030

BibTeX
@article{Levy2026,
  author = {Levy, Jerrold H and Shaw, Joseph R and Siegal, Deborah M and Callum, Jeannie and Frere, Corinne and Karkouti, Keyvan and Maier, Cheryl L and Mazzeffi, Michael and Samama, C Marc and Shorr, Risa and Tanaka, Kenichi A and Dyke, Cornelius M and Connors, Jean M},
  title = {Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {11},
  pages = {3853--3864},
  doi = {10.1016/j.jtha.2026.07.030}
}
Kostenlos starten →